ENZC
Enzolytics Inc

19,873
Mkt Cap
$1.58M
Volume
2.83M
52W High
$0.0019
52W Low
$0.00
PE Ratio
-4.00
ENZC Fundamentals
Price
$0.0003
Prev Close
$0.0004
Open
$0.0004
50D MA
$0.0004
Beta
-0.09
Avg. Volume
19.21M
EPS (Annual)
-$0.0003
P/B
-0.02
Loading...
Loading...
Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company’s all-human monoclonal antibodies target and neutralize human immunodeficiency virus and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19. Its proprietary therapeutic is also being tested against Hepatitis A, B and C, Rheumatoid Arthritis, certain forms of cancer, rabies, influenza A and B, tetanus, and diphtheria. The company was founded on July 28, 2004 and is headquartered in Allen, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Enzolytics Inc?
What is the 52-week high for Enzolytics Inc?
What is the 52-week low for Enzolytics Inc?
What is Enzolytics Inc stock price today?
What was Enzolytics Inc stock price yesterday?
What is the PE ratio of Enzolytics Inc?
What is the Price-to-Book ratio of Enzolytics Inc?
What is the 50-day moving average of Enzolytics Inc?

Latest ENZC News

View
No ENZC news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.